[0004] แลคโตเฟอร์ริน, an iron-binding glycoprotein, is one of the major
multifunctional agents present in human milk. It has the capacity to bind two molecules of iron in a reversible fashion and can facilitate the uptake of iron within the intestines.
[0005] Zinc Sulfate has the molecular formula ZnSO4. Generally zinc is an
essential trace mineral that needs to be provided by the diet. Zinc is required for the biological function of more than 300 enzymes and stabilizes the tertiary structure of
some proteins. In the central nervous system, zinc may be concentrated in the synaptic vesicles of specific glutaminergic neurons, which are found primarily in the forebrain and connect with other cerebral structures.
[0006] อัลลิล sulfide, also commonly known as diอัลลิล sulfide is an สารประกอบ ออร์กาโนซัลเฟอร์ with the chemical formula C6Fl1oS. อัลลิล sulfides, for example diอัลลิล sulfide, diอัลลิล ไดซัลไฟด์, and diอัลลิล trisulfide, are principle constituents of garlic oil. In vivo อัลลิล sulfide may be converted to diอัลลิล sulfoxide and diอัลลิล sulfone by cytochrome P450 2E1 (CYP2E1).
[0007] ซัลโฟราเฟน ("SFN") is a molecule within the isothiocyanate group of สารประกอบ ออร์กาโนซัลเฟอร์s having the molecular formula C6H11NOS2. SFN and its
isomers, for example L-ซัลโฟราเฟน ("L-SFN"), are known to exhibit anti-cancer and antimicrobial properties in experimental models. SFN may be obtained from
cruciferous vegetables, such as broccoli, Brussels sprouts or cabbage. SFN is
produced when the enzyme myrosinase reacts with glucoraphanin, a glucosinolate, transforming glucoraphanin into SFN.
[0008] What is needed is a method for promoting neuronal health and
development, by administering a composition that ประกอบรวมด้วย a neurologic component, in order to support brain and nervous system health. The neurologic component
includes แลคโตเฟอร์ริน, at least one สารประกอบ ออร์กาโนซัลเฟอร์, and สารรวมของมัน. These nutritional compositions disclosed herein may have additive and/or synergistic nervous system health benefits. Accordingly, the disclosure is directed to methods of promoting and supporting brain and nervous system health by providing a nutritional composition ซึ่งประกอบรวมด้วย a neurologic component.
DISCLOSURE OF THE INVENTION
[0009] Briefly, the การเปิดเผยนี้ is directed, in an embodiment, to a method for promoting neuronal development by providing a nutritional composition ซึ่งประกอบรวมด้วย a neurologic component ที่รวมถึง แลคโตเฟอร์ริน, zinc sulfate, at least one ออร์กาโนซัลเฟอร์
compound, and/or สารรวมของมัน. Suitable non-limiting examples of
สารประกอบ ออร์กาโนซัลเฟอร์s include ALA, อัลลิล sulfide, ally' ไดซัลไฟด์, ซัลโฟราเฟน ("SFN"), and/or L-ซัลโฟราเฟน ("L-SFN").
[0010] In certain embodiments the nutritional composition may further ประกอบรวมด้วย a long chain polyunsaturated fatty acid ("LCPUFA"), such as docosahexanoic acid
("DHA"), เซียลิก แอซิด, a prebiotic, a probiotic, fl-glucan, an iron source, fisetin,
Kaempferol, urosolic acid, or ของผสม of one or more thereof.
[0011] Due to critical brain development during the first years of life, in one
embodiment the method includes providing a nutritional composition which ประกอบรวมด้วย an infant formula or a pediatric nutritional composition that includes the neurologic
component described herein. The nutritional compositions described herein may also be useful as medicaments or nutritional supplements for promoting neurological health in subjects with a neural degenerative diseases and/or brain injury. Further, the
nutritional compositions of the การเปิดเผยนี้ may provide neuroprotective health benefits and promote overall brain and nervous system health.
[0012] It is to be understood that both the foregoing general description and the following detailed description present embodiments of the disclosure and are intended to provide an overview or framework for understanding the nature and character of the disclosure as it is claimed. The description serves to explain the principles and
operations of the claimed subject matter. Other and further features and advantages of the การเปิดเผยนี้ will be readily apparent to those skilled in the art upon a reading of the following disclosure.
BRIEF DESCRIPTION OF THE DRAWINGS
[0013] รูป 1A is a phase contrast microscopy image of hADSCs under the
neuronal differentiation condition without treatment of a neurologic component. The
morphology of the hADSCs represents a condition of undifferentiation, with a large and flat morphology, as well as no obvious neurite outgrowth.
[0014] รูป 1B is a phase contrast microscopy image of hADSCs forming
morphologies that resembles bi-polar, tri-polar, and multi-polar neural cells.
[0015] รูป 2A is a phase contrast microscopy image of a control well containing hADSCs with no treatment of a neurologic component or DHA.
[0016] รูป 2B is a phase contrast microscopy image of a control well containing hADSCs with treatment of DHA.
[0017] รูป 2C is a phase contrast microscopy image of a control well containing
hADSCs with treatment of ALA.
BEST MODE FOR CARRYING OUT THE INVENTION
[0018] Reference now will be made in detail to the embodiments of the การเปิดเผยนี้, one or more examples of which are set forth herein below. Each example is provided by way of explanation of the nutritional composition(s) and or methods of the การเปิดเผยนี้ and is not a limitation. In fact, it will be apparent to those skilled in
the art that various modifications and variations can be made to the teachings of the การเปิดเผยนี้ without departing from the scope of the disclosure. For instance, features illustrated or described as part of one embodiment, can be used with another embodiment to yield a still further embodiment.
[0019] Thus, it is intended that the การเปิดเผยนี้ covers such modifications and variations as come within the scope of the appended claims and their equivalents. Other objects, features and aspects of the การเปิดเผยนี้ are disclosed in or are apparent from the following detailed description. It is to be understood by one of
ordinary skill in the art that the present discussion is a description of exemplary
embodiments only and is not intended as limiting the broader aspects of the การเปิดเผยนี้.
[0020] The การเปิดเผยนี้ relates generally to a method for promoting
neuronal health and development, by providing a nutritional composition ซึ่งประกอบรวมด้วย a neurologic component, wherein the neurologic component ประกอบรวมด้วย แลคโตเฟอร์ริน and an สารประกอบ ออร์กาโนซัลเฟอร์ such as ALA. Additionally, the disclosure relates to methods of supporting and promoting brain and nervous system health, การเกิดใหม่ของเซลล์ประสาท and
neuroprotection, and cognitive development by providing a target subject a nutritional composition containing the neurologic component described herein.
[0021] "Nutritional composition" means a substance or formulation that satisfies at least a portion of a subject's nutrient requirements. The terms "nutritional(s)",
"nutritional formula(s)", "enteral nutritional(s)", and "nutritional supplement(s)" are used as non-limiting examples of nutritional composition(s) throughout the present
disclosure. Moreover, "nutritional composition(s)" may refer to liquids, powders, gels, pastes, solids, concentrates, suspensions, or ready-to-use forms of enteral formulas, oral formulas, formulas for infants, formulas for pediatric subjects, formulas for children, growing-up milks and/or formulas for adults.
The term "enteral" means deliverable through or within the gastrointestinal, or digestive, tract. "Enteral administration" includes oral feeding, intragastric feeding, transpyloric administration, or any other administration into the digestive tract. "Administration" is broader than "enteral administration" and includes parenteral administration or any
other route of administration by which a substance is taken into a subject's body.
[0022] A "neurologic component" refers to a compound or compounds, or a
composition, that affects การเกิดใหม่ของเซลล์ประสาท, either by promoting or inhibiting การเกิดใหม่ของเซลล์ประสาท. Thus, in some cases, a neurologic component promotes การเกิดใหม่ของเซลล์ประสาท, while in other
cases, a neurologic component inhibits or reduces การเกิดใหม่ของเซลล์ประสาท, as compared to the degree of การเกิดใหม่ของเซลล์ประสาท when the neurologic component is not provided.
[0023] "Alpha-lipoic acid", abbreviated "ALA" herein, refers to an สารประกอบ ออร์กาโนซัลเฟอร์ derived from octanoic acid having the molecular formula C8H14S202.
Generally, ALA contains two sulfur atoms attached via a ไดซัลไฟด์ bond. Alpha-lipoic acid is synonymous with lipoic acid, abbreviated "LA", and the two terms and
abbreviations may be used interchangeable herein.
[0024] As used herein "ซัลโฟราเฟน" includes any known isomers of
ซัลโฟราเฟน ที่รวมถึง but not limited to L-ซัลโฟราเฟน. In some embodiments,
ซัลโฟราเฟน may include only L-ซัลโฟราเฟน while, in other embodiments, the
reference to ซัลโฟราเฟน may include L-ซัลโฟราเฟน, D-ซัลโฟราเฟน, any other
suitable isomer of ซัลโฟราเฟน, and any สารรว